Search research articles
Contact Us
Filters
Showing results (151-160 of 165) with videos related to
Page
of 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 24, 2020
Randomized Trial Comparing Double Versus Triple Bortezomib-Based Regimen in Patients With Multiple Myeloma and Acute Kidney Injury Due to Cast Nephropathy
Frank Bridoux, Bertrand Arnulf, Lionel Karlin, et al.
Nature Communications
|
March 28, 2025
A mouse model of cardiac immunoglobulin light chain amyloidosis reveals insights into tissue accumulation and toxicity of amyloid fibrils
Gemma Martinez-Rivas, Maria Victoria Ayala, Sebastien Bender, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
August 24, 2023
Rare Variants in Complement Gene in C3 Glomerulopathy and Immunoglobulin-Mediated Membranoproliferative GN
Marie Sophie Meuleman, Paula Vieira-Martins, Carine El Sissy, et al.
Kidney International
|
April 25, 2025
Renal Pathology Society/International Kidney and Monoclonal Gammopathy Research Group consensus on pathologic definitions and terminology of monoclonal gammopathy-associated kidney lesions
Samih H Nasr, Virginie Royal, Alejandro Best Rocha, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 31, 2017
PKD2-Related Autosomal Dominant Polycystic Kidney Disease: Prevalence, Clinical Presentation, Mutation Spectrum, and Prognosis
Emilie Cornec-Le Gall, Marie-Pierre Audrézet, Eric Renaudineau, et al.
Journal of the American Society of Nephrology : JASN
|
May 6, 2024
Complement Terminal Pathway Activation and Intrarenal Immune Response in C3 Glomerulopathy
Marie-Sophie Meuleman, Florent Petitprez, Matthew C Pickering, et al.
American Journal of Hematology
|
October 26, 2018
Carfilzomib weekly 20/56 mg/m<sup>2</sup> , lenalidomide and dexamethasone for early relapsed refractory multiple myeloma
Valentine Richez, Cecile Gruchet, Stephanie Guidez, et al.
Kidney International
|
December 29, 2022
Pathological characteristics of light chain crystalline podocytopathy
Samih H Nasr, Satoru Kudose, Vincent Javaugue, et al.
The Lancet. Oncology
|
July 6, 2023
Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group
Meletios A Dimopoulos, Giampaolo Merlini, Frank Bridoux, et al.
Journal of the American Society of Nephrology : JASN
|
August 12, 2015
Spectrum and Prognosis of Noninfectious Renal Mixed Cryoglobulinemic GN
Mohamad Zaidan, Benjamin Terrier, Agnieszka Pozdzik, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 165) with videos related to
Sort By:
Page
of 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 24, 2020
Randomized Trial Comparing Double Versus Triple Bortezomib-Based Regimen in Patients With Multiple Myeloma and Acute Kidney Injury Due to Cast Nephropathy
Frank Bridoux, Bertrand Arnulf, Lionel Karlin, et al.
Nature Communications
|
March 28, 2025
A mouse model of cardiac immunoglobulin light chain amyloidosis reveals insights into tissue accumulation and toxicity of amyloid fibrils
Gemma Martinez-Rivas, Maria Victoria Ayala, Sebastien Bender, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
August 24, 2023
Rare Variants in Complement Gene in C3 Glomerulopathy and Immunoglobulin-Mediated Membranoproliferative GN
Marie Sophie Meuleman, Paula Vieira-Martins, Carine El Sissy, et al.
Kidney International
|
April 25, 2025
Renal Pathology Society/International Kidney and Monoclonal Gammopathy Research Group consensus on pathologic definitions and terminology of monoclonal gammopathy-associated kidney lesions
Samih H Nasr, Virginie Royal, Alejandro Best Rocha, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
March 31, 2017
PKD2-Related Autosomal Dominant Polycystic Kidney Disease: Prevalence, Clinical Presentation, Mutation Spectrum, and Prognosis
Emilie Cornec-Le Gall, Marie-Pierre Audrézet, Eric Renaudineau, et al.
Journal of the American Society of Nephrology : JASN
|
May 6, 2024
Complement Terminal Pathway Activation and Intrarenal Immune Response in C3 Glomerulopathy
Marie-Sophie Meuleman, Florent Petitprez, Matthew C Pickering, et al.
American Journal of Hematology
|
October 26, 2018
Carfilzomib weekly 20/56 mg/m<sup>2</sup> , lenalidomide and dexamethasone for early relapsed refractory multiple myeloma
Valentine Richez, Cecile Gruchet, Stephanie Guidez, et al.
Kidney International
|
December 29, 2022
Pathological characteristics of light chain crystalline podocytopathy
Samih H Nasr, Satoru Kudose, Vincent Javaugue, et al.
The Lancet. Oncology
|
July 6, 2023
Management of multiple myeloma-related renal impairment: recommendations from the International Myeloma Working Group
Meletios A Dimopoulos, Giampaolo Merlini, Frank Bridoux, et al.
Journal of the American Society of Nephrology : JASN
|
August 12, 2015
Spectrum and Prognosis of Noninfectious Renal Mixed Cryoglobulinemic GN
Mohamad Zaidan, Benjamin Terrier, Agnieszka Pozdzik, et al.
Page
of 17